|Awarded On||November 16, 2016|
|Title||Biodegradable nanoclusters for molecular cancer imaging|
|Award Mechanism||Individual Investigator|
|Institution/Organization||The University of Texas M.D. Anderson Cancer Center|
|Principal Investigator/Program Director||Konstantin Sokolov|
Ovarian cancer is the deadliest gynecologic malignancy that results in an estimated 150,000 death per year including ca. 14,000 women in the USA alone. Significant efforts in improving patient outcomes including cancer free survival and cure from the disease are focused on early detection, prevention and identifying the best course of therapy. However, the lack of reliable biomarkers has been associated with a slow progress and difficulties in optimizing various strategies; currently, most validation approaches are based on clinical trials requiring a large number of patients and a long time to achieve results. There is an urgent critical need for a technology that would allow sensitive a...